Press Release | December 6, 2018
Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space
Read More
News | November 27, 2018
Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy
Read More
News | November 20, 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Read More
News | November 5, 2018
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering
Read More
